|
|
|
| |
| About Me |
| |
Curriculum Vitae
Lixia Yao
1451 E 55th Street
Apt 717N
Chicago, IL 60615
(646) 300-5036
firstname.lastname @ dbmi . columbia . edu |
Educational Background
08/05-present Columbia University , New York , NY
Department of Biomedical Informatics, PhD Candidate
Research topic: drug target analysis and prediction by computational methods (under supervision of Dr. Andrey Rzhetsky)
07/02-07/04 National University of Singapore , Singapore
Department of Computational Science, Masters of Science
Thesis: Inhibitor prediction by machine learning approaches
09/98-07/02 Dalian University of Technology, P.R. China
Department of Chemical Engineering, Bachelor of Engineering
Thesis: Morphological Control of Nano Particles of Alumina
|
Research/Professional Experience
01.2006-present: Dr. Andrey Rzhetsky's lab, Columbia University
drug target analysis and prediction by computational methods
Current drug targets are analyzed in the context of a literature-based molecular network in order to identify some characteristics or patterns of drug targets. Specifically five tasks are achieved: (1) to identify macroscopical properties of drug targets; (2) to study topological properties of drug targets in a biological network; (3) to examine tissue selectivity of drug targets; (4) to verify the clusterability of drug targets for different disease categories; (5) to check the gene expression levels of drug targets in different tissues.
09.2005-12.2005: Dr. Andrea Califano's lab, Columbia Univeristy
Evidence integration of GeneWays and Aracne
When reconstructing a genome-wide biological network, there are many supporting evidences, such as microarray data, colocalization information, and literature reports. It is found that many predictions which yield complete and accurate cellular networks are based on moderate and consistent evidence from multiple sources rather than strong evidence from a single source. I aim to use Bayesian Network to integrating GeneWays (literature evidence) and Aracne (microarray prediction) and investigate its capability at reconstructing genetic regulatory network.
The fundamental idea is to assess each source of evidence for interactions by comparing it against samples of known positives and negatives ("gold standards"), yielding a statistical reliability. Then, extrapolating genome-wide, I predict the chance of possible interactions for every gene pair by combining each independent evidence source according to its reliability.
09.2004-12.2004: Department of Chemistry, Rensselaer Polytechnic Institute
Comparative study of docking/scoring functions based on Trypsin inhibitor
Scoring function is one of the most important elements of docking programs. In this project, three docking/scoring softwares, namely SYBYL, MOE, and GRAMM, are evaluated in terms of their sampling and scoring algorithms. The benchmark protein-ligand complex used is a Trypsin protein and its inhibitor Benzamidine.
07.2002-06.2004: Department of Computational Science, National University of Singapore
Inhibitor Prediction by Machine Learning Approaches
Three widely used algorithms from machine learning community were explored to facilitate inhibitor prediction for three pharmacologically important proteins. The aim was to evaluate the feasibility of introducing these machine learning approaches to lead identification and its ADME/toxicity properties analysis. Specifically, I worked on the inhibitor/antagonist prediction for a therapeutic target (5-HT2), an adverse reaction target (cholinesterase) and an ADME associated protein (CYP3A4). The machine learning approaches used include decision tree, k-nearest neighbor and support vector machine, and preprocessing techniques such as normalization and principal component analysis. Quantitative Structure Activity Relationship (QSAR) methods were used to extract features from 3D structures of small molecules.
|
Teaching Experience
01/03-12/03 National University of Singapore , Singapore
08/04-05/05 Rensselaer Polytechnic Institute
Teaching Assistant of Organic Chemistry Laboratory I & II
01/07-05/07 Columbia University
|
Other Experience
05/07-08/07 GlacoSmithKline, Collegeville, PA
Summer internship, translational medicine analysis based on biomarker capturing. I compare and evaluate nested ANOVA and t-test et al on microarray data obtained from in-house cell line samples and clinical samples (patient biopsy).
|
Publications
- Quantitative Systems-level determinants of human genes targeted by successful drugs. L. Yao and A. Rzhetsky (submitted 2007)
- Internet Resources for Proteins Associated with Drug Therapeutic Effects, Adverse Reactions, and ADME. Z. L. Ji, L. Z. Sun, X. Chen, C. J. Zheng, L. X. Yao , L. Y. Han, Z.W. Cao,oJ. F. Wang, W. K. Yeo, C.Z. Cai, and Y. Z. Chen. Drug Discovery Today , 8(12),526-529. (2003).
- KDBI:Kinetic Data of Bio-molecular Interactions Database. Z. L. Ji, X. Chen, C. J. Zheng, L.X. Yao , L. Y. Han , W. K. Yeo, P. C. Chung, H. S. Puy, Y. T. Tay, A. Muhammad, and Y. Z. Chen. Nucleic. Acids. Res ., 31(1), 255-257. (2003).
|
Computer Skills
Familiar with molecular modeling/bioinformatics techniques, e.g. QSAR, docking, sequence alignment, homology modeling and machine learning. Proficient at Matlab, Perl, mySQL, HTML, and UNIX OS
|
Affiliations
American Medical Informatics Association
New York Academy of Sciences
|
|
|
| |
|
|
|
Copyright (c) Lixia
Yao Last update on Sept
2007 |
 |
|
|